Stock listing

Stockholm:EXPRS2 ExpreS2ion Biotech Holding AB Aktie

Home listing (Stockholm) of ExpreS2ion Biotech Holding AB

Follow ExpreS2ion Biotech Holding AB into a list and get an email when it puts out news.

Share price · OMXSTO:EXPRS2

0.934 SEK 0.000 (0.0%)

Close on Oct 30, 2026

Past year -84.9% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
0.934 – 0.950 SEKOct 30, 2026
Volume
36,006 sharesOct 30, 2026
Market cap
9.23M SEKAt the close on Oct 30, 2026 · price × 9.88M shares outstanding
52-week range
0.880 – 6.980 SEKLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
158,225 SEKMedian day 72,526 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
ExpreS2ion Biotech Holding AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:EXPRS2 · Home0.934 SEK0.000 (0.0%)36,0060.9340.9500.9340.934Close on Oct 30, 2026
Frankfurt:5JD0€0.055 EUR-0.004 (-6.4%)—€0.055€0.055€0.055€0.059Close on Oct 30, 2026

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · OMXSTO:EXPRS2 · SEK, adjusted for splits

DayCloseChange%OpenHighLowVolume
0.9340.0000.0%0.9340.9500.93436,006
0.934-0.096-9.3%0.9981.0100.934117,309
1.030-0.010-1.0%1.0401.0400.96020,299
1.040+0.050+5.1%1.0001.0450.92877,809
0.990-0.060-5.7%1.0501.0500.900307,308
1.050-0.030-2.8%1.0151.1050.980264,441
1.080+0.020+1.9%0.9781.0800.96846,533
1.0600.0000.0%1.0601.0700.96816,809
1.060+0.040+3.9%1.0001.0601.00028,020
1.020-0.010-1.0%0.9661.0450.95626,676
1.0300.0000.0%0.9801.0600.96630,117
1.0300.0000.0%0.9021.0300.880292,957
1.030-0.060-5.5%1.0901.0900.914146,931
1.090+0.010+0.9%1.0951.0951.03074,702
1.080-0.010-0.9%1.0901.1401.02078,301
1.090+0.035+3.3%1.0401.1501.04065,645
1.055-0.005-0.5%1.0601.0600.98253,473
1.060-0.065-5.8%1.1251.1251.04029,230
1.125+0.005+0.4%1.1301.1301.09085,393
1.120+0.025+2.3%1.1201.1251.08053,873
1.095-0.070-6.0%1.1051.1501.080162,264
1.165-0.025-2.1%1.1951.1951.13537,655
1.190+0.025+2.1%1.1651.2001.090140,322
1.165+0.050+4.5%1.0801.1651.07050,192
1.115-0.015-1.3%1.1301.1351.08537,111
1.130+0.005+0.4%1.1151.1501.08041,912
1.125-0.055-4.7%1.1701.1701.04073,211
1.180-0.025-2.1%1.2051.2351.18040,671
1.205-0.025-2.0%1.2351.2351.19572,526
1.230-0.090-6.8%1.3201.3201.21070,631
1.320+0.020+1.5%1.3001.3201.24039,187
1.300-0.030-2.3%1.2251.3251.22528,716
1.330+0.005+0.4%1.3451.3901.27563,425
1.325+0.075+6.0%1.2951.4001.290201,136
1.2500.0000.0%1.2501.3001.20533,844
1.250-0.005-0.4%1.2151.3551.21522,555
1.255-0.030-2.3%1.2851.2851.20574,080
1.285-0.065-4.8%1.3051.3251.28515,547
1.3500.0000.0%1.2901.3701.29054,480
1.350+0.005+0.4%1.3701.3701.28535,265
1.345-0.050-3.6%1.3201.3751.29047,307
1.395+0.065+4.9%1.3301.4001.250158,636
1.330-0.085-6.0%1.3251.4101.27033,613
1.415+0.110+8.4%1.3001.4151.25576,290
1.305+0.005+0.4%1.3001.3101.23587,583
1.300+0.055+4.4%1.2451.3001.21034,418
1.245-0.035-2.7%1.2751.2901.150338,627
1.280-0.100-7.2%1.3951.3951.100546,063
1.380+0.040+3.0%1.3351.4001.300174,168
1.340-0.060-4.3%1.4001.4001.30549,385
1.400+0.015+1.1%1.4451.4451.325362,557
1.385-0.010-0.7%1.4251.4901.310223,360
1.395+0.095+7.3%1.2801.4851.220494,293
1.300-0.050-3.7%1.3501.3801.280152,332
1.350-0.085-5.9%1.4351.4351.305263,037
1.435-0.010-0.7%1.4451.4651.360153,649
1.445-0.015-1.0%1.4501.4651.355109,137
1.460-0.065-4.3%1.6601.7301.340955,706
1.525+0.065+4.5%1.4751.6001.450149,147
1.460+0.035+2.5%1.4601.5401.460129,070
1.425+0.015+1.1%1.4351.4901.405140,624
1.410+0.075+5.6%1.3351.4401.335104,683
1.335-0.055-4.0%1.3901.3901.330135,123
1.390-0.025-1.8%1.3801.4151.35071,819
1.415-0.015-1.0%1.4301.4301.38025,946
1.430+0.020+1.4%1.4101.4401.38064,692
1.410+0.025+1.8%1.4101.4451.41048,692
Ticker
Stockholm:EXPRS2
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Stockholm
Currency
SEK

What changed lately

Calls

Replays

  • Expres2ion Biotech Holding (Stockholm:EXPRS2) Q2 2026 Earnings Call

    Thu, Aug 20, 2026 · 4:00 AM ET

    Watch Transcript

  • Expres2ion Biotech Holding (Stockholm:EXPRS2) Q1 2026 Earnings Call

    Thu, May 28, 2026 · 4:00 AM ET

    Watch Transcript

  • Expres2ion Biotech Holding (Stockholm:EXPRS2) Q4 2025 Earnings Call

    Thu, Feb 19, 2026 · 3:00 AM ET

    Watch Transcript

Latest news

ExpreS2ion Biotech Obtains Commitment for Warrant Program TO 13 and enters into SEK 50 Million Put Option Agreement with lead investor Alumni Capital

Sep 14, 2026

Closed 1.33 (+6.0%) on Sep 15, 2026

ExpreS2ion Announces Financial Results for the Second Quarter and First Half of 2026

Aug 20, 2026

Closed 1.39 (-0.7%) on Aug 20, 2026

ExpreS2ion annual report for 2025 published

Jun 4, 2026

Closed 1.63 (+0.9%) on Jun 4, 2026

ExpreS2ion Announces Financial Results for the First Quarter of 2026

May 28, 2026

Closed 1.66 (-0.3%) on May 28, 2026

ExpreS2ion resolves on a set-off issue to one guarantor in connection with completed rights issue

May 11, 2026

Closed 1.98 (+2.9%) on May 12, 2026

ExpreS2ion Biotech: Rights issue outcome – SEK31.8m raised

May 5, 2026

Closed 1.97 (+0.3%) on May 5, 2026

ExpreS2ion announces final outcome of its rights issue of units

May 4, 2026

Closed 1.97 (+0.3%) on May 5, 2026

ExpreS2ion Biotech advances breast cancer project with rights issue of SEK 53 million

Apr 20, 2026

Closed 2.37 (+3.9%) on Apr 20, 2026

ExpreS2ion featured in BioStock investor presentation as subscription period opens in SEK 53 million rights issue

Apr 16, 2026

Closed 2.28 (-2.6%) on Apr 17, 2026

ExpreS2ion publishes prospectus in connection with SEK 53 million rights issue to complete Phase I and support partnering activities

Apr 14, 2026

Closed 3.55 (-27.6%) on Apr 14, 2026

All ExpreS2ion Biotech Holding AB news

Financings

  • New shares on exercise of TO 13 warrants and directed issue to guarantor

    Sep 14, 2026 · US$1.98M

    Announced: SEK 19.3M–SEK 32.4M · SEK 1.6 a share · Vator Securities +2

    Dealers: Vator Securities, SCHMIDT Capital Advisors, APREA Partners

    Buyers: Vator Securities (guarantee undertaking totalling SEK 19.3 million); Alumni Capital; Tellus Equity AB; Leif Helth Jensen; John Haurum; Thomas Larsson

    Use of proceeds: Complete the ES2B-C001 Phase I study, strengthen licensing negotiations, platform and CMC development, and business development

    Announced Sep 14, 2026

  • New shares under put option agreement

    Sep 14, 2026 · US$5.12M

    Announced: up to SEK 50M

    Buyers: Alumni Capital Limited (commitment of up to SEK 50,000,000 in equity financing over 24 months)

    Announced Sep 14, 2026

Read by 6ix AI from the company's releases

Decks

ExpreS2ion Biotech Holding AB on 6ix

Sector
Health care
Industry
Biotechnology
News releases
12 in the last 12 months · 12 in all · newest Sep 14, 2026 · oldest 2026
Calls
10 calls with a replay · 10 with a transcript · latest Aug 20, 2026
Decks
52 decks · latest Oct 7, 2026

Where ExpreS2ion Biotech Holding AB is listed

ListingExchangeCountryCurrency
Stockholm:EXPRS2 · Home listing · This pageStockholmSwedenSEK
LS Exchange:A40P4HLS ExchangeGermanyEUR
Lang & Schwarz:A40P4HLang & SchwarzGermanyEUR
gettex:5JD0gettexGermanyEUR
Stuttgart:5JD0StuttgartGermanyEUR
Frankfurt:5JD0FrankfurtGermanyEUR
Munich:5JD0MunichGermanyEUR

Log in to ask 6ix AI your own questions about ExpreS2ion Biotech Holding AB.